Kowa Research Institute, Inc.
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.kowaus.com
A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT06525311
- Locations
- π―π΅
301, Yufu, Japan
πΊπΈArizona Liver Health, Chandler, Arizona, United States
πΊπΈSouthern California Research Center, Inc, Coronado, California, United States
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.
- Conditions
- Primary Biliary Cholangitis
- Interventions
- Drug: K-808 (Dose A)Drug: K-808 (Dose B)Drug: Placebo
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT06247735
- Locations
- πΊπΈ
Southern California Research Center - Coronado, Coronado, California, United States
πΊπΈCedars-Sinai Medical Center, Los Angeles, California, United States
πΊπΈVelocity Clinical Research, Santa Ana, California, United States
A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
- Conditions
- Fuchs Endothelial Corneal Dystrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT05826353
- Locations
- πΊπΈ
Keck Hospital of USC, Los Angeles, California, United States
πΊπΈMacy Eye Center, Los Angeles, California, United States
πΊπΈByers Eye Institute at Stanford, Palo Alto, California, United States
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
- Conditions
- Fuchs Endothelial Corneal Dystrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 107
- Registration Number
- NCT05795699
- Locations
- πΊπΈ
Jules Stein Eye Institute, Los Angeles, California, United States
πΊπΈByers Eye Institute at Stanford, Palo Alto, California, United States
πΊπΈSacramento Eye Consultants, Sacramento, California, United States
Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05722262
- Locations
- πΊπΈ
PPD - Austin Research Unit, Austin, Texas, United States
A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
- Conditions
- Corneal Edema After Cataract Surgery
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 331
- Registration Number
- NCT05528172
- Locations
- πΊπΈ
Eye Care Specialists, Kingston, Pennsylvania, United States
πΊπΈCenter for Sight, Las Vegas, Nevada, United States
πΊπΈHouston Eye Associates, Houston, Texas, United States
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 644
- Registration Number
- NCT05403827
- Locations
- πΊπΈ
Trinity Research Group, Dothan, Alabama, United States
πΊπΈOrange County Ophthalmology Medical Group, Garden Grove, California, United States
πΊπΈLoBue Laser and Eye Medical Center, Murrieta, California, United States
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05327127
- Locations
- πΊπΈ
Centricity Research, Columbus, Georgia, United States
πΊπΈBirmingham Digestive Health Research, Inc., Birmingham, Alabama, United States
πΊπΈAdobe Clinical Research, LLC, Tucson, Arizona, United States
Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT04742218
- Locations
- πΊπΈ
PPD Development, LP, Austin, Texas, United States
A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT04484428
- Locations
- πΊπΈ
Lotus Clinical Research, LLC, Pasadena, California, United States